Genetic engineering isn’t easy. Sure, modern synbio techniques are easier than techniques of yore, but there are still a lot of challenges that researchers face.
I was fortunate enough to get a chance to sit down a while back with Svetlana Sapelnikova, the VP of Business Development Strategy at KMT
If I were a betting man, I would say that all of you know at least one person who has been affected by heart disease.
My passion is sharing stories about both life science innovation and design. If you enjoy what you’re reading, please sign up to receive updates!